Phillip A. Sharp - Aug 15, 2022 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Phillip A. Sharp
Stock symbol
ALNY
Transactions as of
Aug 15, 2022
Transactions value $
-$6,623,670
Form type
4
Date filed
8/17/2022, 04:07 PM
Previous filing
Jun 2, 2022
Next filing
May 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $903K +30K $30.09* 30K Aug 15, 2022 Direct F1
transaction ALNY Common Stock Options Exercise $234K +3.67K +12.23% $63.86 33.7K Aug 15, 2022 Direct F1
transaction ALNY Common Stock Sale -$22.2K -98 -0.29% $226.16 33.6K Aug 15, 2022 Direct F1
transaction ALNY Common Stock Sale -$278K -1.22K -3.63% $228.33 32.4K Aug 15, 2022 Direct F1, F2
transaction ALNY Common Stock Sale -$2.67M -11.6K -35.85% $229.93 20.8K Aug 15, 2022 Direct F1, F3
transaction ALNY Common Stock Sale -$3.73M -16.2K -77.99% $230.71 4.57K Aug 15, 2022 Direct F1, F4
transaction ALNY Common Stock Sale -$893K -3.85K -84.35% $231.65 715 Aug 15, 2022 Direct F1, F5
transaction ALNY Common Stock Sale -$166K -715 -100% $232.81 0 Aug 15, 2022 Direct F1, F6
holding ALNY Common Stock 267K Aug 15, 2022 by Trust F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Options Exercise $0 -3.67K -100% $0.00* 0 Aug 15, 2022 Common Stock 3.67K $63.86 Direct F1, F8
transaction ALNY Stock Option (right to buy) Options Exercise $0 -30K -100% $0.00* 0 Aug 15, 2022 Common Stock 30K $30.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2022.
F2 Sale prices ranged from $228.00 to $228.80.
F3 Sale prices ranged from $229.29 to $230.29.
F4 Sale prices ranged from $230.30 to $231.30.
F5 Sale prices ranged from $231.31 to $232.26.
F6 Sale prices ranged from $232.53 to $233.16.
F7 Includes shares held by the Phillip A. Sharp Revocable Trust, of which the reporting person and his spouse are co-trustees. Also includes shares held in trust for the benefit of the reporting persons children, of which the reporting persons children and spouse are the trustees.
F8 The stock option was fully vested as of 12/31/14.